BCTG Acquisition Corp.
Status: Closed Deal
U=S
| IPO Proceeds, $M | $166.75M |
|---|---|
| IPO Date | Sep 3, 2020 |
| CEO | Aaron I. Davis |
| Left Lead | SVB Securities |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | Tango Therapeutics |
| Deal Announced | Apr 14, 2021 |
| Deal Size, $M | $352.75M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Aug 9, 2021 |
| Amendment Vote | TBD |
| Closing Date | Aug 10, 2021 |
Formerly BCTG
TNGX
| Price | $1.36 |
|---|---|
| Last closing price | $1.49 |
| H/L, today | $1.34 / $1.55 |
| H/L, 52-week | $2.47 / $13.03 |
| Volume, today | 507,547 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.